SCHEMBL21363961

SCHEMBL21363961

Cc1cccc(C)c1-c1cncc(-c2c3ccccc3c(-c3cncc(-c4c(C)cccc4C(C)(C)C)c3)c3ccccc23)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.38
GABRB2 P47870 1/20 0.38
NR1H2 P55055 7/20 0.33
NR1H3 Q13133 5/20 0.33
KIF11 P52732 1/20 0.33
CYP2A6 P11509 3/20 0.32
ESR1 P03372 1/20 0.32
ALOX5AP P20292 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
CA2 P00918 1/20 0.31
TRPA1 O75762 1/20 0.31
ALDH1A1 P00352 1/20 0.31
SRC P12931 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP11B1 P15538 1/20 0.30
CYP11B2 P19099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21363954 0.87 CYP2A6 (0.39) CYP2A6ALOX5APKDM4ELMNAHTT
SCHEMBL21363958 0.77 LMNA (0.39) CYP2A6ALOX5APLMNAALDH1A1CYP1A2
SCHEMBL21364025 0.75 S1PR4 (0.36) CYP2A6ALOX5APKDM4ELMNAALDH1A1
SCHEMBL21363955 0.75 NOS3 (0.37) CYP2A6ALOX5APKDM4ELMNAHTT
SCHEMBL21364096 0.74 ALOX5AP (0.41) CYP2A6ALOX5APKDM4ELMNATRPA1
SCHEMBL29235924 0.73 GABRA1 (0.50) GABRA1GABRB2KIF11LMNAHTT
SCHEMBL21363959 0.73 GABRA1 (0.35) GABRA1GABRB2NR1H2NR1H3KIF11
SCHEMBL14877302 0.71 GABRA1 (0.60) GABRA1GABRB2KIF11CYP2A6KDM4E
SCHEMBL21476134 0.70 CYP2A6 (0.50) CYP2A6SRCCYP11B1CYP11B2
SCHEMBL4411468 0.69 KIF11 (0.48) GABRA1GABRB2KIF11CYP2A6CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145821-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2021-10-12 US disclosed
US-20190288216-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145821-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device LEF1, SLC25A21, EMC2 GABRA1 4553/4885GABRB2 4403/4885NR1H2 1959/4885
US-20190288216-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE LEF1, SLC25A21, EMC2 GABRA1 4553/4885GABRB2 4403/4885NR1H2 1959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.